Renaissance Technologies's VRNA Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 615,900 shares of Verona Pharma plc (VRNA) worth $65.72 M, representing 0.09% of the portfolio. First purchased in 2019-Q1, this medium-term investment has been held for 18 quarters.
Based on 13F filings, Renaissance Technologies has maintained a strategic position in VRNA, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 468,500 shares. Largest reduction occurred in Q4 2022, reducing 210,100 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's Verona Pharma plc (VRNA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Verona Pharma plc (VRNA) Trades by Renaissance Technologies
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2019 | +11,700 | New Buy | 11,700 | $6.50 |
| Q2 2019 | -1,400 | Reduce 11.97% | 10,300 | $5.15 |
| Q3 2019 | -10,300 | Sold Out | 0 | $0.00 |
| Q4 2019 | +12,500 | New Buy | 12,500 | $5.76 |
| Q1 2020 | -12,500 | Sold Out | 0 | $0.00 |
| Q2 2020 | +21,410 | New Buy | 21,410 | $4.67 |
| Q3 2020 | -21,410 | Sold Out | 0 | $0.00 |
| Q4 2020 | +24,800 | New Buy | 24,800 | $7.02 |
| Q1 2021 | -24,800 | Sold Out | 0 | $0.00 |
| Q2 2022 | +28,200 | New Buy | 28,200 | $4.18 |
| Q3 2022 | +181,900 | Add 645.04% | 210,100 | $10.22 |
| Q4 2022 | -210,100 | Sold Out | 0 | $0.00 |
| Q2 2024 | +31,044 | New Buy | 31,044 | $14.46 |
| Q3 2024 | -31,044 | Sold Out | 0 | $0.00 |
| Q4 2024 | +15,500 | New Buy | 15,500 | $46.44 |
| Q1 2025 | +83,500 | Add 538.71% | 99,000 | $63.49 |
| Q2 2025 | +48,400 | Add 48.89% | 147,400 | $94.58 |
| Q3 2025 | +468,500 | Add 317.84% | 615,900 | $106.71 |
Renaissance Technologies's Verona Pharma plc Investment FAQs
Renaissance Technologies first purchased Verona Pharma plc (VRNA) in Q1 2019, acquiring 11,700 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held Verona Pharma plc (VRNA) for 18 quarters since Q1 2019.
Renaissance Technologies's largest addition to Verona Pharma plc (VRNA) was in Q3 2025, adding 615,900 shares worth $65.72 M.
According to the latest 13F filing for Q3 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 615,900 shares of Verona Pharma plc (VRNA), valued at approximately $65.72 M.
As of the Q3 2025 filing, Verona Pharma plc (VRNA) represents approximately 0.09% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies's peak holding in Verona Pharma plc (VRNA) was 615,900 shares, as reported at the end of Q3 2025.